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Background: Prune belly syndrome is a rare congenital malformation of unknown aetiology and is characterised
by abnormalities of the urinary tract, a deficiency of abdominal musculature and bilateral cryptorchidism in males.
We report a case of prune belly syndrome from Papua New Guinea, which was suspected on pregnancy ultrasound
scan and confirmed upon delivery.
Case presentation: A 26-year-old married woman, Gravida 3 Para 2, presented to antenatal clinic in Madang,
Papua New Guinea, at 21+5 weeks’ gestation by dates. She was well with no past medical or family history of note.
She gave consent to participate in a clinical trial on prevention of malaria in pregnancy and underwent repeated
ultrasound examinations which revealed a live fetus with persistent megacystis and anhydramnios. Both mother
and clinicians agreed on conservative management of the congenital abnormality. The mother spontaneously
delivered a male fetus weighing 2010 grams at 34 weeks’ gestation with grossly abnormal genitalia including
cryptorchidism, penile aplasia and an absent urethral meatus, absent abdominal muscles and hypoplastic lungs. The
infant passed away two hours after delivery. This report discusses the implications of prenatal detection of severe
congenital abnormalities in PNG.
Conclusion: This first, formally reported, case of prune belly syndrome from a resource-limited setting in the
Oceania region highlights the importance of identifying and documenting congenital abnormalities. Women
undergoing antenatal ultrasound examinations must be carefully counseled on the purpose and the limitations of
the scan. The increasing use of obstetric ultrasound in PNG will inevitably result in a rise in prenatal detection of
congenital abnormalities. This will need to be met with adequate training, referral mechanisms and better
knowledge of women’s attitudes and beliefs on birth defects and ultrasound. National medicolegal guidance
regarding induced abortion and resuscitation of a fetus with severe congenital abnormalities may be required.
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First described by Frölich in 1839 [1], prune belly syn-
drome (PBS), also known as Eagle-Barrett syndrome [2]
or Obrinsky syndrome [3], is a congenital disorder af-
fecting 2.5 to 3.8 per 100,000 live births [4,5]. It is largely
but not exclusively confined to males [4,6], and is de-
fined clinically by a combination of abnormalities of the
urinary tract such as the absence or partial obstruction
of the urethra and renal dysplasia, a deficiency of ab-
dominal musculature and bilateral cryptorchidism in
males [7]. Other fetal malformations which may be asso-
ciated with PBS include gastrointestinal, cardiac, pul-
monary and limb abnormalities [8]. Prenatal ultrasound
features can include oligo- or anhydramnios, megacystis,
hydronephrosis, and hyperechogenic kidneys [9]. To
date, a clear genetic basis for PBS has not been established
and the aetiology of the syndrome is unknown [10]. It
is thought that PBS arises from a defect in the inter-
mediate and lateral plate mesoderm development dur-
ing the 6th to 10th week of gestation, resulting in
clinical abnormalities [9,11,12].
In high-income countries, most cases of PBS are diag-
nosed antenatally through ultrasound, and confirmed at
birth [9,13]. By contrast, in resource-limited settings
such as Papua New Guinea (PNG) prenatal diagnosis of
congenital abnormalities remains unreported, and docu-
mentation of congenital abnormalities observed after de-
livery is rare [14-17].
The use of ultrasound to complement antenatal care
in PNG is relatively recent [18] and is restricted to a
small number of facilities or medical research projects
[19]. It depends on the presence of specialists with ultra-
sound training (obtained abroad), and machines are usu-
ally donated and rarely procured through governmental
funds. Scans are not provided routinely as part of ante-
natal care in PNG; however, when available and clinically
indicated, women are referred for confirmation of gesta-
tional age, diagnosis of multiple gestation, and assess-
ment of suspected placental and amniotic fluid level
abnormalities.
This is the first formal report of PBS in PNG and
other resource-limited settings in the South Pacific, and
was first suspected on ultrasound. It highlights chal-
lenges clinicians in PNG are facing when counseling af-
fected parents on diagnosis and prognosis of severe
congenital abnormalities detected prenatally.
Case presentation
The mother of the patient was a 26-year-old, married,
Gravida 3 Para 2 (two healthy children 5 and 3 years
old, uncomplicated spontaneous vaginal deliveries at
term) who presented to an urban clinic in Madang,
PNG, in April 2012 for routine antenatal booking of a
planned pregnancy at 21+5 weeks’ gestation by dates.The mother gave informed written consent to join a
randomised controlled trial that took place at the clinic at
the time. The purpose of the trial was to examine the effect
of intermittent preventive therapy in pregnancy (IPTp)
with azithromycin and sulphadoxine-pyrimethamine (SP)
on reducing the proportion of babies born with low birth-
weight [20,21], and women were followed up until delivery.
As part of the study, participants were offered an ultra-
sound examination (USS) by a research clinician
(Logiqbook XP, General Electric Medical Systems,
Little Chalfont, UK). The main purpose of the scan
was to corroborate clinical history and examination data
by providing an additional, more accurate estimate of
gestational age (to detect preterm births) and to screen
for twin pregnancies. Scans were performed during a
separate research ultrasound clinic visit within a week
of enrollment into the study.
Upon presentation the mother was well and had no
complaints. There was no past medical and family history
of note. She was a non-smoker, had not consumed alcohol
during this pregnancy, and had a normal body mass index
(20.1 kg/m2). She reported regular fetal movements since
19 weeks’ gestation. Observations taken on the day were
normal for gestation (blood pressure 88/54, heart rate: 86
beats per minute, temperature 36.5°C). On abdominal pal-
pation the fundal height was 23 cms. A fetal heart rate of
144 beats per minute was observed, fetal lie was longi-
tudinal and presentation was cephalic. She was mildly
anaemic (haemoglobin = 9.6 g/dL) (Hemocue, Quest
Diagnostics, Madison, USA) and was given dietary advice.
She received IPTp with azithromycin 1g twice daily for
two days and a single dose of SP of 1500/75 mg as per trial
protocol.
The mother underwent three ultrasound scans (USS)
in total: the first ultrasound examination was performed
by a research clinician two days after initial presentation
at 22+0 weeks, at which time the fetal abnormality was
detected. The mother was withdrawn from study treat-
ments and referred to the hospital clinical team. The
research clinician conducted a further ultrasound exam-
ination at 24+1 weeks, which was followed by a third
USS was performed at 24+3 weeks’ gestation at hospital.
All scans confirmed a single fetus with a normal fetal
heart rate (152 – 158 beats per minute), a large and
distended fetal bladder (megacystis), anhydramnios,
and compressed fetal abdominal and thoracic contents
(Figure 1). In view of the observed abnormalities only
head circumference, biparietal diameter and femur length
measurements were included on first scan to estimate ges-
tational age (EGA): using standard charts [22], the EGA
was 22+1, which was in agreement with gestational age
by dates. During the same ultrasound examination the
distended bladder measured 4.6 × 3.6 × 4.8 cms. The key-







Figure 1 Prenatal ultrasound findings of a case of prune-belly
syndrome in Papua New Guinea. A. Sagittal view – 1) megacystis,
2) anhydramnios, and 3) marked compression of abdominal and
thoracic contents by the bladder. B. Coronal view - 1) megacystis
and 2) anhydramnios. C. Umbilical artery Doppler at an estimated
22+1 weeks’ gestation.
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eteric dilatation (not shown). Umbilical artery flow indices
were abnormal for gestational age on Doppler performed
at second scan: the systolic:diastolic ratio (2.37), resistance
index (0.55) and pulsatility index (0.77) were all below the
5th percentile using standard reference charts [23-25].
These indicators of a low placental vascular resistance
have not been confirmed as predictors of fetal outcome
[26], and Doppler findings were not used in clinical deci-
sion making.
The mother was admitted to hospital at 24+3 weeks’
gestation for further assessment and a provisional diag-
nosis of megacystis and anhydramnios secondary to
urethral obstruction or atresia was made. The mother
(partner unavailable) was informed of the likely poor
prognosis. She was counselled about strategies for fur-
ther care, which included conservative management and
termination of pregnancy using misoprostol, as well as
palliative treatment versus resuscitation at delivery. The
mother opted for non-interventional management and
neonatal resuscitation if signs of life were present atbirth. She was discharged and outpatient follow-up by
both study and hospital clinicians was arranged.
The mother returned for one more antenatal visit at
26+5 weeks’ gestation during which she was provided
with IPTp (SP as per national protocol), and iron and
folic acid supplements and albendazole to treat her
worsening anaemia (haemoglobin = 7.6 g/dL). Observa-
tions remained within normal range (35.8°C, blood pres-
sure 98/51, heart rate 65, respiratory rate 20), and the
fundal height was 25 cms.
The mother presented to the Provincial General Hos-
pital in spontaneous labour at 34 weeks’ gestation. On ar-
rival fetal lie was longitudinal, presentation was cephalic
and on baseline vaginal examination her cervix was 2cms
dilated, fully effaced and membranes were intact. The fetal
heart rate was 168 beats per minute. Maternal observa-
tions were normal (temperature 36.3°C, blood pressure
107/66, pulse 74, respiratory rate 20). Shortly after arrival
she entered the active phase of first stage of labour and
after five hours the cervix was fully dilated. The timing of
rupture of membranes was not documented, and absence
of liquor was noted at full dilatation. She delivered an
infant weighing 2010 g (head circumference 290 mms,
abdominal circumference 310 mms, length 440 mms) after
20 mins of second stage labour. At birth the patient had
a pulse rate <100 beats per minute, an irregular respira-
tory rate of approximately 30 breaths per minute, and a
poor response to stimulation (documented Apgar scores
3/1 and 5/5). Neonatal resuscitation was attempted
by midwivery staff, oral suction was performed, and
ventilatory support for the patient was provided using a
bag-valve mask supplied with oxygen at a flow rate of
0.5 L/min. Despite these efforts the patient became in-
creasingly apnoeic and cyanotic. Attending midwives were
unable to pass a nasal oxygen catheter. A decision for
conservative management was made after 20 minutes of
resuscitation. The infant died two hours after delivery.
On physical examination of the newborn performed by
a research clinician multiple abnormalities were noted:
the abdomen was distended, of prune-like appearance
(wrinkled, lose skin) and anterior abdominal wall mus-
culature was absent (Figure 2A); the male genitalia were
severely abnormal, with notable absence of the urethral
meatus, penile aplasia, and a small scrotum with crypt-
orchidism (Figure 2B); the chest was significantly small,
consistent with lung hypoplasia secondary to anhydramnios
(Figure 2A); and the nasal passages were either stenotic or
atretic, although choanal atresia could not be confirmed.
No other abnormalities were observed. Facilities for de-
tailed postmortem examination were unavailable. Since
the patient was taking part in a clinical trial assessing the
safety of SP and azithromycin in second and third trimes-
ter of pregnancy, this case underwent an in-depth review
by the trial’s safety team: in view of the diagnosis of PBS
AB
Figure 2 Clinical findings. A. Newborn’s general appearance –
prune-belly syndrome characteristics include a distended wrinkled
abdomen secondary to absent abdominal musculature, and a
small chest secondary to lung hypoplasia. B. Abnormal male
genitalia: undersized, underdeveloped scrotum with absent testes
(cryptorchidism), penile aplasia and absent urethral meatus.
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short interval between drug administration and detection
by ultrasound, a study drug-linked congenital abnormality
was excluded. Clinical findings and images were discussed
with an external consultant neonatologist (SR) who sup-
ported a diagnosis of PBS. The parents subsequently re-
ceived further counseling from both hospital and study
doctors, and the mother was discharged the following day.
Conclusions
To our knowledge, this is the first case of PBS formally
reported from PNG and other resource-limited regions
in Oceania. In addition, it is the first report from PNG
of prenatal diagnosis of a severe congenital abnormality
using ultrasound technology.
The burden of birth defects in low-resource countries re-
mains relatively under-researched and has been recognised
as a target for studies and surveillance [27,28]. Information
on the prevalence and characteristic of congenital abnor-
malities in PNG is limited [14-17]. Reporting and analysis
of congenital abnormalities from low-resource environ-
ment such as PNG could be improved by establishing
an international online passive surveillance system. Here,clinicians could submit case reports online and receive
additional information and diagnostic support.
The ultrasound findings of anhydramnios and megacystis,
in combination with the notable absence of a urethral
meatus, a hypoplastic chest and the absence of anterior
abdominal wall musculature on physical examination,
strongly support a diagnosis of PBS in this patient, des-
pite the lack of more detailed ultrasound or pathology
data to corroborate these findings. Clinicians did not
have the necessary training and experience to confidently
detect PBS-related abnormalities on ultrasound, such as
polycystic or dysplastic kidneys, hydronephrosis, lung hy-
poplasia, fetal ascites, and absent abdominal wall muscula-
ture [7,9], and autopsy facilities and a pathologist were
unavailable.
PBS comprises a spectrum of mild to severe presenta-
tions [7]. This patient’s prenatal features of persistent mid-
second trimester anhydramnios and megacystis pointed
towards the uniformly lethal end of the spectrum of the
syndrome [29,30]. Although the final diagnosis could only
be made after delivery, a poor prognosis for the fetus was
evident based on the observed ultrasound features alone.
Furthermore, capacities for complex postpartum surgical
interventions [8] are largely absent in PNG. In such clin-
ical circumstances the survival of the fetus is very unlikely
and he should be considered a dying patient [31]. Given
its detection before fetal viability mothers ‘should be
explained the nature and prognosis of the anomaly and
offered both continuation of the pregnancy or induced
abortion’ [31]. This was done in this case, and both
mother and clinicians opted for non-intervention and
monitoring. However, in order to reduce anxiety and the
risks of over- or under-interventions, a more guarded
response to parents may be more appropriate when sig-
nificant uncertainties regarding the prognosis remain.
Further advice should be sought when possible (e.g. ultra-
sound images could be sent elsewhere for verification). If a
clear prognosis cannot be established, delivery should be
awaited and mothers counseled accordingly. Intervention
may then only become necessary should the fetal abnor-
mality pose a threat to the mother’s health, such as hydro-
cephalus, increasing the risk of obstructed labour.
The limitations of ultrasound, and the limitations of
the skill set of those performing ultrasound, must be
highlighted to parents prior to scanning. In hospital
practice, ultrasound complements, not replaces, routine
clinical history and examination. Clarifying the purpose
of the scan with the mother (e.g. dating the pregnancy)
and reiterating that a scan does not rule out problems
(congenital abnormality, obstetric complications) is very
important in order to ensure that no harm is done. This
is even more important when ultrasound is used as part
of medical research. The mother of the patient was
counseled to this effect at enrollment into the trial, was
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of the abnormality, and was promptly referred to, and
reviewed by, the most senior obstetric doctor in the re-
gion. The introduction of ultrasound in obstetric prac-
tice in PNG somewhat compares to introduction of a
completely new medical technology to clinical practice
in a high-income country [32]: it is the clinicians’ respon-
sibility to be adequately trained and experienced prior to
using information gathered through safe application of
this technology to guide subsequent patient management.
Ultrasound can assist doctors greatly but both mothers
and doctors must recognise the limitations of the opera-
tors’ skill set and the technology overall. Introducing a
national training curriculum for obstetric and gynaeco-
logical ultrasound could assist doctors in guiding and
standardising their scanning practice.
It is likely that the large majority of congenital abnor-
malities detected prenatally in PNG will be managed
conservatively. Induced abortion may rarely be opted for
by parents because termination of pregnancy for socio-
economic reasons is illegal in PNG and subject to severe
legal punishment. The only circumstance where termin-
ation is legal is when undertaken by a specialist to save
the life of a pregnant woman (includes preservation of
both physical and mental health) [33]. In view of the
current law (which is based on a British law from 1861
[33], now considerably amended in the UK), active man-
agement of this case (e.g. medical termination of preg-
nancy using misoprostol) could have been illegal. Future
use of ultrasound technology for prenatal diagnostics in
PNG should be carefully implemented in light of existing
laws and ethical considerations.
Prenatal diagnosis of a severe congenital abnormality
with poor prognosis for survival post-delivery must prompt
clinicians to counsel parents regarding resuscitation of the
newborn. Parents’ wishes must be respected, but counsel-
ing should explain the rationale behind no resuscitation or
palliative treatment when there is sufficient certainty of
a lethal outcome. In our case the mother’s request for
neonatal resuscitation to be performed if signs of life
were present at birth was respected. National guidance
is not available but could be based on the principle that
attempting neonatal resuscitation could be guided not
only ‘by aetiology of the baby’s condition, but should
take into account the expected outcome, what is thought
to be the best interests of the baby, and the wishes of
parents’ [34].
PNG is one of the most culturally diverse countries in
the world. In addition to mapping the burden of birth de-
fects in PNG, future research needs to evaluate the accept-
ability of ultrasound as part of antenatal care amongst
women in PNG. Such findings can assist with developing
culturally-appropriate guidelines, as observed elsewhere
[35]. Similarly, understanding beliefs and attitudes towardsbirth defects, and the impact of the latter on the accept-
ability of ultrasound, clinical research, induced abortion
and palliative treatment of affected fetuses is urgently
required.
In summary, prune belly syndrome, a rare congenital
malformation, occurs in Papua New Guinea. Monitoring
and reporting of birth defects in PNG could be im-
proved. Women undergoing antenatal ultrasound exami-
nations must be carefully counseled on the purpose and
the limitations of the scan. The increasing use of obstet-
ric ultrasound in resource-limited settings such as PNG
will inevitably result in a rise in prenatal detection of
congenital abnormalities. This will need to be met with
adequate training, referral mechanisms and better know-
ledge of women’s attitudes and beliefs on ultrasound and
birth defects. National medico-legal guidance regarding
induced abortion and resuscitation of a fetus with severe
congenital abnormalities is required.Consent
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